+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Glucose Testing Market by Product Type (Blood Glucose Meters, Control Solutions, Lancets), Technology (Electrochemical Sensors, Optical Techniques, Thermal Techniques), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Blood Glucose Testing Market by Product Type (Blood Glucose Meters, Control Solutions, Lancets), Technology (Electrochemical Sensors, Optical Techniques, Thermal Techniques), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Blood Glucose Testing Market by Product Type (Blood Glucose Meters, Control Solutions, Lancets), Technology (Electrochemical Sensors, Optical Techniques, Thermal Techniques), End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5094051
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Glucose Testing Market grew from USD 21.21 billion in 2024 to USD 23.40 billion in 2025. It is expected to continue growing at a CAGR of 9.83%, reaching USD 37.24 billion by 2030.

Understanding Blood Glucose Monitoring as a Cornerstone for Personalized Diabetes Care and Enhanced Clinical Decision-Making Across Healthcare Environments

Blood glucose monitoring has evolved from a routine clinical measurement to a transformative tool at the heart of personalized diabetes care. As the prevalence of diabetes continues to rise, accurate and timely glucose data has become indispensable for clinicians and patients alike. This report opens by exploring how innovations in measurement precision and user-centric design are driving a shift toward proactive glucose management.

Moreover, continuous and flash glucose monitoring technologies have redefined the relationship between individuals and their health data. By providing near real-time insights and reducing the burden of manual testing, they enable more informed decision-making and support adaptive treatment strategies. Consequently, both established healthcare providers and novel entrants are investing in platforms that integrate data analytics, mobile connectivity, and telehealth services to enhance patient engagement.

Transitioning from traditional point-of-care approaches to integrated digital ecosystems represents a critical juncture in diabetes management. This introduction frames the subsequent sections by highlighting the convergence of technological innovation, regulatory developments, and shifting patient expectations that collectively shape the modern blood glucose testing landscape.

Identifying Technological Innovations Policy Shifts and Patient Engagement Trends Reshaping the Future of Blood Glucose Testing Ecosystems Worldwide

The blood glucose testing landscape is undergoing transformative shifts driven by a confluence of technological breakthroughs, evolving policy frameworks, and heightened patient engagement. Advanced sensor miniaturization and non-invasive measurement techniques are accelerating device adoption, while software-driven analytics platforms are elevating the role of real-time data in clinical pathways.

Simultaneously, regulatory authorities have introduced updated guidelines aimed at ensuring device accuracy and patient safety. These frameworks not only establish rigorous quality benchmarks but also streamline pathways for responsible product approval and post-market surveillance. As a result, manufacturers are aligning development protocols with global standards to expedite market access and foster cross-border interoperability.

Patient-centric models of care are also reshaping end-user dynamics. Emerging value-based healthcare initiatives prioritize outcomes that hinge on consistent glucose monitoring and proactive intervention. Consequently, telehealth integration and remote monitoring services are gaining traction, enabling healthcare providers to oversee large patient cohorts with enhanced efficiency. These convergent trends underscore a fundamental shift from episodic glucose testing toward continuous care models, forging a more resilient and responsive ecosystem.

Analyzing the Effects of New United States Tariff Structures on the Supply Chain Dynamics and Operational Costs Within the Blood Glucose Testing Industry

Recent adjustments to United States tariff structures have introduced new complexities into the global supply chain for blood glucose testing components. Import duties on critical inputs such as electronic sensors, specialized plastics for lancets, and reagent materials for control solutions have driven up manufacturing costs, compelling producers to reassess sourcing strategies.

In response, leading device manufacturers have explored nearshoring and diversified supplier networks to mitigate exposure to fluctuations in tariff policy. These strategic pivots have enabled continuity of supply while preserving product affordability for end users. Nonetheless, the transitional process has revealed logistical bottlenecks and inventory constraints, especially for high-precision measurement instruments and disposable test strips.

Furthermore, the cumulative impact of these tariff adjustments has catalyzed collaboration between industry associations and regulatory bodies to advocate for harmonized trade agreements. As a result, stakeholders are now engaging in targeted dialogue to balance domestic manufacturing incentives with global market accessibility. Ultimately, these efforts aim to stabilize procurement pipelines and safeguard consistent access to essential testing solutions for patients and healthcare providers alike.

Uncovering Actionable Insights from Diverse Product Technologies End User Dynamics and Distribution Channels in the Global Blood Glucose Testing Market

Insights derived from product and technology segmentation reveal differentiated growth pathways within the blood glucose testing market. Devices ranging from traditional blood glucose meters to control solutions and lancets coexist alongside advanced sensors designed for continuous or flash monitoring, reflecting diverse clinician and patient preferences. Underlying this diversity, electrochemical sensor technologies remain predominant, while optical and thermal approaches are gaining traction where non-invasive measurement is prioritized.

End-user adoption patterns underscore the importance of tailored solutions. Diagnostic laboratories continue to rely on high-precision instruments for patient screening and clinical research, while home care settings demand user-friendly meters with seamless connectivity. Hospitals and clinics, facing both inpatient and outpatient needs, favor integrated systems that merge point-of-care testing with electronic health record platforms.

Distribution channels further influence market dynamics. Hospital pharmacies serve as critical touchpoints for acute care environments, while online pharmacies enable subscription-based delivery models that enhance patient adherence. Retail pharmacies bridge consumer access and professional guidance, particularly in regions where over-the-counter availability coexists with structured diabetes education programs. Together, these segmentation insights highlight the necessity for manufacturers to align product portfolios with specific channel requirements and evolving end-user expectations.

Examining Regional Variations and Growth Drivers Across Americas Europe Middle East Africa and Asia-Pacific in Blood Glucose Monitoring Adoption

Regional variations in blood glucose monitoring adoption reflect differences in healthcare infrastructure, reimbursement frameworks, and patient awareness across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, a confluence of private and public insurance models supports widespread access to both traditional meters and advanced continuous monitoring systems, fostering competitive innovation among device makers.

Across Europe Middle East & Africa, heterogeneous regulatory landscapes coexist with initiatives to expand diabetes screening programs. Emerging telehealth networks and cross-border healthcare collaborations are pivotal in bridging care gaps, particularly in underserved markets where diabetes prevalence is rising.

In Asia-Pacific, rapid urbanization and digital health investments are catalyzing growth in home-based monitoring solutions. Government-sponsored wellness campaigns and mobile health applications are enhancing patient engagement, while local manufacturers increasingly partner with international firms to co-develop culturally adapted devices. These regional insights underscore the importance of agile market entry strategies and localized value propositions.

Profiling Leading Innovators Strategic Collaborations and Competitive Differentiators Driving Advancement in Blood Glucose Testing Solutions and Service Offerings

Leading companies in the blood glucose testing domain are differentiating through integrated hardware-software ecosystems and strategic partnerships. Global diagnostics firms have expanded portfolios with continuous and flash monitoring offerings, while emerging technology specialists are introducing wearable devices that leverage machine learning to predict glycemic trends.

Collaborative alliances between device manufacturers, data analytics firms, and pharmaceutical companies are accelerating the development of closed-loop insulin delivery systems. Such synergies not only enhance clinical efficacy but also open new service-based revenue streams through remote patient monitoring and subscription models.

Beyond product innovation, key players are investing in manufacturing scalability and quality assurance processes to meet stringent regulatory expectations. Investments in Asia-Pacific production facilities and established distribution networks in the Americas illustrate a commitment to operational resilience. Collectively, these company-level strategies are shaping a competitive landscape defined by technological leadership and adaptable go-to-market approaches.

Formulating Strategic Recommendations to Enhance Competitive Positioning and Accelerate Value Creation in the Evolving Blood Glucose Monitoring Landscape

To capitalize on emerging opportunities in blood glucose monitoring, industry leaders should prioritize digital integration across device portfolios and patient care pathways. Embedding predictive analytics capabilities within monitoring platforms can enhance personalized treatment regimens and drive value-based outcomes.

Simultaneously, supply chain diversification remains essential to mitigate geopolitical and tariff-related risks. Establishing strategic manufacturing partnerships in key regions and adopting agile inventory management practices will safeguard continuity and cost stability.

Engaging proactively with regulatory bodies to align on quality standards and approval processes can accelerate market entry. Furthermore, stakeholder collaboration with healthcare providers and patient advocacy groups will ensure product designs resonate with real-world needs. By embracing these strategic imperatives, organizational leaders can fortify their market positioning and drive sustainable growth within the evolving blood glucose testing landscape.

Detailing Research Approaches Data Acquisition Protocols and Analytical Frameworks Employed to Ensure Accuracy Credibility and Comprehensive Coverage

This study employed a comprehensive research framework combining primary insights and secondary data to ensure methodological rigor. Primary research initiatives included in-depth interviews with clinical endocrinologists, diabetes educators, regulatory experts, and supply chain managers, providing nuanced perspectives on real-world challenges and innovation priorities.

Secondary sources encompassed peer-reviewed journals, industry publications, and regulatory agency databases, which were systematically reviewed to validate emerging trends and technological milestones. Data triangulation techniques were applied to reconcile insights across multiple sources, ensuring consistency and reliability.

Analytical processes leveraged both qualitative thematic analysis and quantitative assessment of historical performance indicators, enabling a balanced view of market dynamics. A multi-layered quality assurance protocol, including peer reviews and expert validation, further underpins the credibility and comprehensiveness of the findings presented herein.

Summarizing Key Discoveries Implications for Stakeholders and the Path Forward for Blood Glucose Testing Advancements and Improved Patient Outcomes

In summary, blood glucose testing has entered a new phase characterized by advanced sensor technologies, integrated digital platforms, and patient-centric care models. Regulatory shifts and tariff adjustments are reshaping supply chain strategies, while regional market dynamics underscore the importance of localized approaches.

Key segmentation, regional, and competitive insights reveal pathways for differentiation, from home-based monitoring innovations to strategic manufacturing diversifications. The actionable recommendations outlined herein provide a roadmap for stakeholders seeking to navigate this complex landscape and deliver enhanced clinical outcomes.

As the industry continues to converge around data-driven, personalized solutions, organizations that align their investments with regulatory priorities and end-user needs will be best positioned to lead the next wave of growth and innovation in blood glucose monitoring.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Blood Glucose Meters
    • Control Solutions
    • Lancets
    • Sensors
      • Continuous Glucose Monitoring Sensors
      • Flash Glucose Monitoring Sensors
    • Test Strips
  • Technology
    • Electrochemical Sensors
    • Optical Techniques
    • Thermal Techniques
  • End User
    • Diagnostic Laboratories
    • Home Care
    • Hospitals And Clinics
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • 77 Elektronika Kft.
  • Abbott Laboratories
  • ACON Laboratories, Inc
  • AgaMatrix, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Medical Ltd.
  • Becton Dickinson and Company
  • Beurer Belgium
  • Dexcom, Inc.
  • i-SENS, Inc.
  • Johnson & Johnson
  • LifeScan IP Holdings, LLC
  • Medtronic PLC
  • Neogen Corporation
  • Nipro Corporation
  • Nova Biomedical
  • Roche Diagnostics Nederland BV
  • Rossmax International Ltd.
  • Sanofi S.A.
  • Sinocare Inc.
  • Terumo Corporation
  • Trividia Health, Inc.
  • VivaChek Laboratories Inc.
  • Medisana AG
  • ForaCare Suisse AG
  • Omron Healthcare, Inc.
  • Microlife AG
  • Merck KGaA

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of continuous glucose monitoring systems integrated with smartphone applications to enhance real-time data tracking and patient engagement
5.2. Emergence of non-invasive glucose sensing technologies leveraging spectroscopy and optical sensors for pain-free monitoring experiences
5.3. Expansion of AI-driven predictive analytics in blood glucose management to forecast hyperglycemic and hypoglycemic events
5.4. Growing demand for personalized diabetes management platforms offering customized insulin dosing recommendations based on user-specific glucose patterns
5.5. Rise of cloud-based remote monitoring solutions enabling healthcare providers to access patient glucose data for telemedicine consultations
5.6. Development of implantable biosensors with long-term stability for continuous subcutaneous glucose measurement in chronic diabetes care
5.7. Integration of wearable glucose monitoring devices with digital therapeutics to support lifestyle interventions and medication adherence
5.8. Increasing focus on advanced test strip chemistry to improve accuracy and reduce interference from hematocrit and medications
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood Glucose Testing Market, by Product Type
8.1. Introduction
8.2. Blood Glucose Meters
8.3. Control Solutions
8.4. Lancets
8.5. Sensors
8.5.1. Continuous Glucose Monitoring Sensors
8.5.2. Flash Glucose Monitoring Sensors
8.6. Test Strips
9. Blood Glucose Testing Market, by Technology
9.1. Introduction
9.2. Electrochemical Sensors
9.3. Optical Techniques
9.4. Thermal Techniques
10. Blood Glucose Testing Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Home Care
10.4. Hospitals And Clinics
11. Blood Glucose Testing Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Americas Blood Glucose Testing Market
12.1. Introduction
12.2. Canada
12.3. Brazil
12.4. Argentina
12.5. Mexico
12.6. United States
13. Europe, Middle East & Africa Blood Glucose Testing Market
13.1. Introduction
13.2. Russia
13.3. Nigeria
13.4. Egypt
13.5. France
13.6. Switzerland
13.7. Netherlands
13.8. Italy
13.9. Poland
13.10. Sweden
13.11. South Africa
13.12. Germany
13.13. Qatar
13.14. Finland
13.15. United Kingdom
13.16. United Arab Emirates
13.17. Denmark
13.18. Saudi Arabia
13.19. Israel
13.20. Turkey
13.21. Norway
13.22. Spain
14. Asia-Pacific Blood Glucose Testing Market
14.1. Introduction
14.2. India
14.3. Taiwan
14.4. South Korea
14.5. Singapore
14.6. China
14.7. Malaysia
14.8. Philippines
14.9. Australia
14.10. Vietnam
14.11. Thailand
14.12. Indonesia
14.13. Japan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. 77 Elektronika Kft.
15.3.2. Abbott Laboratories
15.3.3. ACON Laboratories, Inc
15.3.4. AgaMatrix, Inc.
15.3.5. ARKRAY, Inc.
15.3.6. Ascensia Diabetes Care Holdings AG
15.3.7. B. Braun Medical Ltd.
15.3.8. Becton Dickinson and Company
15.3.9. Beurer Belgium
15.3.10. Dexcom, Inc.
15.3.11. i-SENS, Inc.
15.3.12. Johnson & Johnson
15.3.13. LifeScan IP Holdings, LLC
15.3.14. Medtronic PLC
15.3.15. Neogen Corporation
15.3.16. Nipro Corporation
15.3.17. Nova Biomedical
15.3.18. Roche Diagnostics Nederland BV
15.3.19. Rossmax International Ltd.
15.3.20. Sanofi S.A.
15.3.21. Sinocare Inc.
15.3.22. Terumo Corporation
15.3.23. Trividia Health, Inc.
15.3.24. VivaChek Laboratories Inc.
15.3.25. Medisana AG
15.3.26. ForaCare Suisse AG
15.3.27. Omron Healthcare, Inc.
15.3.28. Microlife AG
15.3.29. Merck KGaA
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BLOOD GLUCOSE TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BLOOD GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BLOOD GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BLOOD GLUCOSE TESTING MARKET: RESEARCHAI
FIGURE 24. BLOOD GLUCOSE TESTING MARKET: RESEARCHSTATISTICS
FIGURE 25. BLOOD GLUCOSE TESTING MARKET: RESEARCHCONTACTS
FIGURE 26. BLOOD GLUCOSE TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BLOOD GLUCOSE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY BLOOD GLUCOSE METERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY BLOOD GLUCOSE METERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY CONTROL SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY CONTROL SOLUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY LANCETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY LANCETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY FLASH GLUCOSE MONITORING SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY FLASH GLUCOSE MONITORING SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TEST STRIPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TEST STRIPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY ELECTROCHEMICAL SENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY ELECTROCHEMICAL SENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY OPTICAL TECHNIQUES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY OPTICAL TECHNIQUES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY THERMAL TECHNIQUES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY THERMAL TECHNIQUES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 63. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 64. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 65. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 66. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 67. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 68. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 69. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 76. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 77. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 78. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 79. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 84. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 85. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 86. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 87. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 88. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 89. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. ARGENTINA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 96. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 97. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 98. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 99. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 127. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 130. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 131. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 132. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 133. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 140. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 141. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 142. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 143. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. NIGERIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 150. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 151. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. EGYPT BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 160. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 161. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 162. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 163. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 170. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 171. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 172. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 173. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. SWITZERLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 178. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 179. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 180. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 181. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 182. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 183. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. NETHERLANDS BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 190. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 191. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 192. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 193. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 198. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 199. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 200. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 201. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. POLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 210. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 211. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 212. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 213. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. SWEDEN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 220. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 222. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. SOUTH AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 230. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 231. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 232. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 233. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 240. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 241. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 242. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 243. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. QATAR BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 250. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 251. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. FINLAND BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 280. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 281. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. DENMARK BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 290. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 292. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 299. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 300. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 301. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 302. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 303. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. ISRAEL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 310. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 311. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 312. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 313. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. TURKEY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 318. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 319. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 320. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 321. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 322. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 323. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. NORWAY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 328. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 329. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2024 (USD MILLION)
TABLE 330. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2025-2030 (USD MILLION)
TABLE 331. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 332. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 333. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 336. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 337. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 338. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 339. ASIA-PA

Samples

Loading
LOADING...

Companies Mentioned

  • 77 Elektronika Kft.
  • Abbott Laboratories
  • ACON Laboratories, Inc
  • AgaMatrix, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Medical Ltd.
  • Becton Dickinson and Company
  • Beurer Belgium
  • Dexcom, Inc.
  • i-SENS, Inc.
  • Johnson & Johnson
  • LifeScan IP Holdings, LLC
  • Medtronic PLC
  • Neogen Corporation
  • Nipro Corporation
  • Nova Biomedical
  • Roche Diagnostics Nederland BV
  • Rossmax International Ltd.
  • Sanofi S.A.
  • Sinocare Inc.
  • Terumo Corporation
  • Trividia Health, Inc.
  • VivaChek Laboratories Inc.
  • Medisana AG
  • ForaCare Suisse AG
  • Omron Healthcare, Inc.
  • Microlife AG
  • Merck KGaA

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 23.4 Billion
Forecasted Market Value ( USD ) by 2030 $ 37.24 Billion
Compound Annual Growth Rate9.8%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Blood Glucose Test Strips Market by Enzyme Technology (Glucose Dehydrogenase, Glucose Oxidase), Product Type (Professional, Self Monitoring), End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Blood Glucose Test Strips Market by Enzyme Technology (Glucose Dehydrogenase, Glucose Oxidase), Product Type (Professional, Self Monitoring), End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Point-of-Care Glucose Testing - Global Strategic Business Report - Product Image

Point-of-Care Glucose Testing - Global Strategic Business Report

  • Report
  • 201 Pages
  • Global
From
Point-of-Care Glucose Testing: Market Share, and Growth Analysis by Product Type (Blood Glucose Meters, Continuous Glucose Monitoring Systems), Application, End User, Technology - Product Image

Point-of-Care Glucose Testing: Market Share, and Growth Analysis by Product Type (Blood Glucose Meters, Continuous Glucose Monitoring Systems), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Blood Glucose Monitoring Systems - Global Strategic Business Report - Product Image

Blood Glucose Monitoring Systems - Global Strategic Business Report

  • Report
  • 456 Pages
  • Global
From
Blood Glucose & Lipid Analyzer Market by Product (Blood Glucose Analyzer, Combined Analyzer, Lipid Analyzer), Test Type (Blood Glucose Test, Lipid Profile Test), Mode, End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Blood Glucose & Lipid Analyzer Market by Product (Blood Glucose Analyzer, Combined Analyzer, Lipid Analyzer), Test Type (Blood Glucose Test, Lipid Profile Test), Mode, End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.